Skip to main content

Vitrolife

Vitrolife AB is a Swedish medical technology company focused on developing, manufacturing, and marketing products for in vitro fertilization treatment. The company produces nutrient culture media, disposable surgical needles, embryo transfer catheters, micro-pipettes, time-lapse incubation systems, and genetic testing solutions for assisted reproduction. Primary revenue streams are derived from the sale of IVF media, disposable medical devices, capital equipment for embryology labs, and reproductive genetic testing services. Vitrolife serves fertility clinics, reproductive health centers, public and private hospitals, and clinical IVF specialists globally. The enterprise holds a leading international market position in culture media and embryo incubation equipment for reproductive medicine. Vitrolife AB is headquartered in Gothenburg, Sweden, and its common shares are listed on Nasdaq Stockholm.

23 of the funds FundTelligence covers report a position in Vitrolife.

Legal name
Vitrolife AB
Sector
Health Care
Country
Sweden
Funds holding it
23
Exposure themes
Reproductive health, Treatment, Women's Health

Funds holding Vitrolife

Showing the 8 largest of 23 funds holding it.

Loading...